Frontiers | Novel Insights from Tumor Immune Microenvironments in the Prognosis Prediction and Treatment Guidance of Bladder Cancer

Novel Insights from Tumor Immune Microenvironments in the Prognosis Prediction and Treatment Guidance of Bladder Cancer

5,807
Total downloads
17k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 10 Aug 2023

Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumor

Liang-Kang Huang
Yu-Ching Lin
Hai-Hua Chuang
Cheng-Keng Chuang
See-Tong Pang
Chun-Te Wu
Ying-Hsu Chang
Kai-Jie Yu
Po-Hung Lin
4 more
I-Hung Shao

doi 10.3389/fonc.2023.1180888

1,106 views

ORIGINAL RESEARCH

Published on 09 Aug 2023

Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer

Xiaolong Jia
Dongxu Zhang
Cheng Zhou
Zejun Yan
Zhaohui Jiang
Liping Xie
Junhui Jiang

doi 10.3389/fonc.2023.1175183

1,616 views

ORIGINAL RESEARCH

Published on 13 Jul 2023

Identify and validate RUNX2 and LAMA2 as novel prognostic signatures and correlate with immune infiltrates in bladder cancer

Yi Jin
Siwei Huang
Zhanwang Wang

doi 10.3389/fonc.2023.1191398

1,629 views
3 citations

ORIGINAL RESEARCH

Published on 05 Jul 2023

Development of a dynamic risk system for predicting the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer after thulium laser resection of bladder tumor or transurethral resection of bladder tumor followed by intravesical BCG instillation

Jian-Xuan Sun
Ye An
Meng-Yao Xu
Chen-Qian Liu
Jin-Zhou Xu
Qi-Dong Xia
Shao-Gang Wang

doi 10.3389/fonc.2023.1133161

1,177 views

ORIGINAL RESEARCH

Published on 15 Jun 2023

Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer

Meng Zhang
Junlong Zhu
Pan Zhang
Lingxun Li
Min Min
Tinghao Li
Weiyang He

doi 10.3389/fonc.2023.1174252

1,870 views
5 citations

ORIGINAL RESEARCH

Published on 30 May 2023

Construction of T cell exhaustion model for predicting survival and immunotherapy effect of bladder cancer based on WGCNA

Yuwen Xue
Guanghui Zhao
Xiaoxin Pu
Fangdong Jiao

doi 10.3389/fonc.2023.1196802

1,671 views
4 citations

ORIGINAL RESEARCH

Published on 14 Apr 2023

Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma

Yunxun Liu
Jun Jian
Ye Zhang
Lei Wang
Xiuheng Liu
Zhiyuan Chen

doi 10.3389/fonc.2023.1170893

3,550 views
3 citations

DATA REPORT

Published on 20 Mar 2023

Mutations in genes encoding innate immune molecules identified in bladder cancer samples as potential biomarkers for immunotherapy with BCG and agonists

Nina Marí Gual Pimenta de Queiroz
Fabio Mambelli
Bruno Marques Silva
Sergio Costa Oliveira

doi 10.3389/fruro.2023.984967

758 views
1 citation

Share on

Frontiers in Urology

Urologic Oncology

Participating Journals

Frontiers in Oncology
- Genitourinary Oncology
- 3.5 impact factor
- 6.2 citescore

Impact

17kTopic views
10kArticle views
5,807Article downloads

View impact

Submit your idea

Articles

Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumor

Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer

Identify and validate RUNX2 and LAMA2 as novel prognostic signatures and correlate with immune infiltrates in bladder cancer

Development of a dynamic risk system for predicting the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer after thulium laser resection of bladder tumor or transurethral resection of bladder tumor followed by intravesical BCG instillation

Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer

Construction of T cell exhaustion model for predicting survival and immunotherapy effect of bladder cancer based on WGCNA

Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma

Mutations in genes encoding innate immune molecules identified in bladder cancer samples as potential biomarkers for immunotherapy with BCG and agonists

Frontiers in Urology

Participating Journals

Impact